Novo Nordisk is raising the stakes in its push to outbid rival Pfizer for the development-stage drugmaker Metsera. Metsera says Novo is now offering to pay as much as $10 billion for Metsera, up from a previous bid for up to $9 billion that sparked litigation from Pfizer. Metsera said Pfizer also has changed an…… MORE




